Pay in 4 interest-free payments of $25.00 Learn more
Ships within 48 hours · Estimated delivery Jul 27 - Aug 1
Srikanth Appikonda
ISCK03 also inhibits p44/42 ERK mitogen-activated protein kinase (MAPK) phosphorylation
The Quad Pill was approved by the FDA in August 2012 for use in the United States and is owned by Gilead Sciences
7 nM) and does not activate human M3 receptor (hM3)
N-Formyl-Met-Leu-Phe promotes bone formation in zebrafish and rabbits
(3S, 4S)-PF-06459988 03 (methanesulfonate) Srikanth Appikonda(3S, 4S) PF 06459988 is the S enantiomer of PF 06459988 with less active. PF 06459988 is a potent irreversible inhibitor of T790M mutant epidermal growth factor receptor (EGFR). PF 06459988 has excellent selectivity against EGFR wild type while possessing a minimally reactive electrophile that reduces the propensity of off target labeling. Product information CAS Number: 1858291 14 1 Molecular Weight: 431. 88 Formula: C19H22ClN7O3 Chemical Name: 1
US$ 607.50
US$ 848.00